CloudMD (TSXV:DOC) - President & CEO, Karen Adams
President & CEO, Karen Adams
Source: Snapclarity.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • CloudMD Software & Services Inc. (DOC) has launched a telemedicine and physical health coaching service along with its Kii Personalized & Connected Care offering
  • Kii is an employer health and wellness solution and the new service will help with personalized treatment plans
  • Specialists are trained to give comprehensive initial medical assessments, psychosocial healthcare support and treatment for most primary and mental healthcare issues
  • The program has already shown positive results with high usage and satisfaction rates
  • CloudMD Software & Services Inc. (DOC) is up 2.63 per cent and is trading at $0.39 per share as of 3:11 p.m. ET

CloudMD Software & Services (DOC) has launched a telemedicine and physical health coaching service along with its Kii Personalized & Connected Care offering.

The company calls Kii its flagship employer health and wellness solution and its new telemedicine medical care program is meant to provide a personalized treatment plan led by healthcare specialists.

“As part of its holistic employer healthcare offering, these services will now be available nationwide through 24/7 digital and telephone options to employees and their family members… and ensures access to important and often simultaneous treatment of physical and mental health issues,” Karen Adams, President and Interim CEO of CloudMD, said.

According to CloudMD, nurses and nurse practitioners on the program are trained to give comprehensive initial medical assessments, psychosocial healthcare support and treatment for most primary and mental healthcare issues.

CloudMD stated its mental health coach program has shown positive results with high usage and satisfaction rates.

“Employers can depend on CloudMD to have a deep understanding of the workplace healthcare environment and health benefits available to employees and focus on personalized engagement that ensures access to care while prioritizing return to function,” Adams said.

CloudMD Software & Services Inc. (DOC) is up 2.63 per cent and is trading at $0.39 per share as of 3:11 p.m. ET.

More From The Market Herald
Emerald Health Therapeutics Inc. - Director & Chairman, Jim Heppell.

" Emerald Health (CSE:EMH) shareholders approve merger

Emerald Health Therapeutics (EMH), has received shareholders’ approval for the proposed plan of arrangement with Skye Bioscience Inc.
Mydecine Innovations Group - CEO, Josh Bartch.

" Mydecine (NEO:MYCO) raises $244K and shifts management team

Mydecine Innovations Group (MYCO) has signed a common share subscription agreement with a third-party investor for proceeds up to $244,99.50.
PharmaDrug - CEO, Daniel Cohen

" PharmaDrug (CSE:PHRX) completes milestone to support cGMP production of PD-001

PharmaDrug (PHRX) has laid the groundwork to support cGMP production of cepharanthine-2HCL for use in the drug product production of PD-001.

" EQ (TSXV:EQ) reports strongest quarter in over a decade

EQ (EQ) reported its financial results for the second quarter ended June 30, 2022, announcing the highest second-quarter revenue in over a decade.